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Disease mechanism: Unravelling Wiskott–Aldrich syndrome
Tomas Kirchhausen* and Fred S. Rosen
The gene responsible for Wiskott–Aldrich syndrome, a
disease affecting platelets and lymphocytes, has been
cloned and its protein product (WASp) found to interact
with the GTPase Cdc42. WASp seems to provide a link
between Cdc42 and the actin cytoskeleton, perhaps
explaining the cellular defects underlying the disease. 
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Jason P. was his parents’ first son. He seemed normal at
birth, but when he was three weeks old, his mother found
bloody diarrhea in his diapers. Jason’s pediatrician perfor-
med a blood count and found normal levels of all cells
except platelets, so the bloody diarrhea was ascribed to
faulty clotting resulting from a deficiency of platelets.
Not only was the platelet count low, at 15 000 ml–1 (a
normal level is more than 150 000 ml–1), the platelets that
were present were also unusually small. The pediatrician
therefore diagnosed Wiskott–Aldrich syndrome (WAS), a
disease characterized by defects in platelets and in
immune function. A few months later, Jason developed
an intensely itchy rash of eczema on his scalp, arms and
legs. The eczema became infected with Staphylococcus
epidermitis because Jason persistently scratched himself.
Shortly thereafter Jason developed the first of several
repeated middle ear infections, which was successfully
treated with antibiotics. At age 3 he developed very severe
and protracted chickenpox.
Fortunately for Jason, he and one of his older sisters
expressed identical proteins of the major histocompatibility
complex (MHC). It was therefore possible to transplant
bone marrow from the healthy sister into Jason. Twenty
days after the transplant, he exhibited complete bone
marrow chimerism, and all his white blood cells had an XX
karyotype, indicating that they developed from progenitors
in his sister’s bone marrow; he subsequently remained in
good health. This case of Wiskott–Aldrich syndrome is
typical: patients have severe defects in platelets and cells of
the immune system (as manifested by susceptibility to
infection and eczema) but other cells of the body are unaf-
fected. The genetic defect underlying Wiskott–Aldrich
syndrome is X-linked, and the gene has recently been
identified [1].
Males with WAS fail to make an immune response to
linear polysaccharide antigens [2,3] and respond poorly to
protein antigens because of defective T-cell–B-cell inter-
actions. Their lymphocytes are morphologically abnormal,
in that they have a paucity of surface microvilli, assume
bizarre shapes, and tend to be smaller than normal (Fig. 1)
[4,5]. WAS platelets are also small: their average diameter
is reduced by about 20 %. Curiously these abnormalities
in cell volume can be largely corrected by surgical removal
of the spleen [6], but it is unclear what perturbation in the
WAS cells is being recognized by the spleen. What
common denominator might explain how these two cell
lineages — lymphocytes and platelets — are affected in
Wiskott–Aldrich syndrome while other cell lineages are
spared?
Three reports have been published recently which show
that the product of the gene affected in WAS
(Wiskott–Aldrich syndrome protein; WASp), interacts
with the small GTP-binding protein Cdc42, a member of
the Rho family of signal transducers. These observations
Figure 1
Scanning electron micrographs of (a) normal
T cells, and (b) WAS T cells, revealing the
differences in morphology described in the
text.
arose from three different approaches. Aspentröm et al. [7],
using a yeast two-hybrid protein–protein interaction
screen with Cdc42 as ‘bait’, found a protein that binds to
Cdc42 and which proved to be WASp. Symons et al. [8],
using a gel-overlay technique with a probe of [g-32P]-
labelled GTP complexed to Cdc42, found a labelled band
of 62 kDa which likewise turned out to be WASp. We
hypothesized that WASp might bind to a small GTP-
binding protein involved in cytoskeletal organization, and
so also found binding of Cdc42 to WASp [9]. All three
groups found that WASp recognizes the GTP-bound and
not the GDP-bound form of Cdc42, and that WASp reacts
minimally or not at all with the Cdc42-related proteins
Rac and Rho. These findings are exciting, because they
connect WASp with a small GTP-binding protein that is
known to regulate the organization of the cytoskeleton,
and in particular the formation of filopodia and lamellipo-
dia [10,11]. That the WASp–Cdc42 interaction does
indeed have such a functional role is suggested by the
observation in one of these three studies [8] that overex-
pression of WASp in transfected cells causes a clustering
of polymerized actin that can be inhibited by simultane-
ous overexpression of a ‘dominant-negative’ mutant form
of Cdc42.
The recent observations allow us to begin to unravel the
enigma posed by the phenotype of the WAS. The immune
response in humans requires, for the most part, physical
contact between T and B lymphocytes. Upon contact, the
T cell polarizes its cytoskeleton toward the B cell [12,13],
and this process seems to be regulated by Cdc42 [14]. In
the absence of functional WASp, suggested to be a down-
stream effector of Cdc42, effective collaboration of T and
B cells might therefore not occur, perhaps helping to
explain the poverty of immune responses in WAS patients.
It is also possible that WASp might regulate actin polymer-
ization in other ways. For example, the carboxy-terminal
portion of WASp contains polyproline stretches reminis-
cent of the proline-rich motifs found in VASP, a protein
that regulates the polymerization of actin through interac-
tions with the actin-binding protein profilin [15]. Further-
more, Symons et al. [8] found that the clustering of actin
induced by overexpressing WASp is not observed with a
truncated WASp missing the carboxy-terminal 59 amino
acids. Whether or not WASp interacts directly with actin or
through actin-binding proteins, in a way similar to VASP, is
an area for further study that might illuminate the morpho-
logical abnormalities in WAS lymphocytes and platelets.
Other aspects of the phenotype of the disease remain
enigmatic and are not readily reconciled with the discov-
ery of WASp’s binding to Cdc42. Circulating lymphocytes
in people with WAS express surface molecules that are
not expressed by resting cells and that immunologists
take to indicate cell activation in response to stimuli (N.
Gerwin, C. Friedrich, F.S.R and J.C. Gutierrez-Ramos,
unpublished observations). Similarly, the platelets in their
blood also seem to be constitutively activated [16]. So, it
seems that WASp functions in a feedback loop that con-
trols or down-regulates activation of these cell lineages.
Indeed, attempts to stimulate T cells cultured from WAS
patients fail to induce the up-regulated transcription of
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Figure 2
A model for how the interaction of Cdc42 and
WASp might be regulated by activated cell-
surface receptors, leading to rearrangements
of the cytoskeleton and modulation of
transcription and cell proliferation.
Receptor
(T-cell receptor ?)
GEF ?
GDP
GTP
Cdc42
SH3
domains Nck
SH2 domain
Protein kinases
and phosphatases
Actin polymerization
WASp
Unknown targets
Actin cytoskeletal organization
Microtubule reorientation
Activation of transcription factors
Cell proliferation
WASp
N C
GTPase-binding domain
238 257
Polyproline-rich SH3-domainbinding site
© 1996 Current Biology
WH1
domain
interleukin-2 that is found in normal cells [17]. But, in
contrast, signalling events such as calcium flux and phos-
phorylation of the T-cell receptor complex occur rapidly
in WAS cells in vitro, just as in normal cells [17]. It there-
fore seems likely that WASp is positioned to exert its
effects prior to the late events, such as transcriptional
induction, but downstream of the early events, such as
receptor phosphorylation (see Fig. 2).
There is no obvious explanation for the findings described
above, but we might infer that WASp plays a role in at
least two (or more) signaling pathways. In fact, the
carboxy-terminal portion of WASp contains several sites
predicted to bind Src homology 3 (SH3) domains, and the
SH3-containing adaptor protein Nck seems also to be a
WASp binding partner [18]. It is to be anticipated that yet
other types of SH3-containing proteins, such as phos-
phatases and kinases, will also interact with WASp. We do
not know the form in which WASp exists inside cells —
whether it is a monomer or oligomerized, and whether or
not it is phosphorylated. WASp may also change its intra-
cellular localization in response to the physiological state
of the cell, and any one of these modifications could influ-
ence its activity. Cell types other than platelets and
lymphocytes do not seem to be affected by WAS mutation,
so it is a logical possibility that a homologous and more
ubiquitous protein(s) may lie at the crossroads between
cytoskeleton organization and signal transduction cascades
in other cell types. 
Finally, there is a surprising effect of WASp. Like all X-
linked genes, the WAS gene is expressed in women from
only one of the two X chromosomes, which ordinarily leads
to mosaicism. But heterozygous women who carry a WAS
mutation exhibit preferential survival of bone marrow
stem cells expressing the normal WAS gene [19]. Thus, all
their blood cells have only wild-type WASp. This observa-
tion suggests a role for WASp in the interaction of bone
marrow stem cells with stromal cells, which leads to stem-
cell differentiation. Nonetheless, the stem cells in males
with the same WAS mutation do survive, although their
progeny lymphocytes are defective [19]. Clearly the dis-
covery of the hitherto unknown WASp protein has pro-
vided a rich arena for many types of investigation of basic
cell biology, and in particular the cell biology of the blood.
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